Nationwide Retrospective Cohort Study on Clinical Outcomes in Rheumatoid Arthritis Patients Treated with JAK Inhibitors

被引：0
|
作者：
Moret, Yurilu Gonzalez [1 ]
Lema, Diego [2 ,3 ]
Quinonez, Fabian Rodriguez [4 ]
机构：
[1] Jefferson Einstein Hosp, Philadelphia, PA USA
[2] Univ Cent Venezuela, Caracas, Venezuela
[3] Univ Wisconsin, Philadelphia, PA USA
[4] Einstein Med Ctr Philadelphia, Philadelphia, PA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1394
引用
收藏
页码：2839 / 2841
页数：3
相关论文
共 50 条
  • [21] Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis
    Taylor, Peter C.
    RHEUMATOLOGY, 2019, 58 : 17 - 26
  • [22] Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
    Se Rim Choi
    Anna Shin
    You-Jung Ha
    Yun Jong Lee
    Eun Bong Lee
    Eun Ha Kang
    Arthritis Research & Therapy, 25
  • [23] Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
    Choi, Se Rim
    Shin, Anna
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [24] Comparative Analysis of Coagulation Activation in Rheumatoid Arthritis Patients Treated With TNF Inhibitors Versus JAK Inhibitors A Longitudinal Study
    Hansildaar, Romy
    Raadsen, Reinder
    Gerritsen, Martijn
    Nagy, Magdolna
    Dijkshoorn, Bas
    Spronk, H. M. H.
    ten Cate, Hugo
    Nurmohamed, M. T.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2024, 30 (08) : e166 - e171
  • [25] Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice A Nationwide Cohort Study From Sweden
    Wadstroem, Hjalmar
    Frisell, Thomas
    Askling, Johan
    JAMA INTERNAL MEDICINE, 2017, 177 (11) : 1605 - 1612
  • [26] EVOLUTION OF RHEUMATOID ARTHRITISASSOCIATED INTERSTITIAL LUNG DISEASE IN PATIENTS TREATED WITH JAK INHIBITORS: A MULTICENTER RETROSPECTIVE STUDY
    Venerito, V.
    Manfredi, A.
    Carletto, A.
    Gentileschi, S.
    Atzeni, F.
    Guiducci, S.
    Lavista, M.
    La Corte, L.
    Pedrollo, E.
    Scardapane, A.
    Tomassini, C.
    Frediani, B.
    Salvarani, C.
    Iannone, F.
    Sebastiani, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 731 - 731
  • [27] Outpatient Use of Antimicrobials in Patients With Rheumatoid Arthritis Before and After Treatment With Tumor Necrosis Factor Inhibitors: A Nationwide Retrospective Cohort Study
    Bjornsson, Aron H.
    Palsson, Olafur
    Kristjansson, Mar
    Gunnarsson, Petur S.
    Grondal, Gerdur
    Gudbjornsson, Bjorn
    Love, Thorvardur J.
    ACR OPEN RHEUMATOLOGY, 2022, 4 (02) : 187 - 194
  • [28] Risk of Cardiovascular Events, Malignancy, and Serious Infection Associated with JAK Inhibitors and TNF Inhibitors in Rheumatoid Arthritis or Ulcerative Colitis: A Nationwide Cohort Study
    Cho, Yongtai
    Yoon, Dongwon
    Khosrow-Khavar, Farzin
    Song, Minkyo
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 9 - 9
  • [29] Does Rheumatoid Arthritis Increase the Risk of COPD? A Nationwide Retrospective Cohort Study
    Chung, Chiwook
    Kim, Hyungjin
    Han, Kyungdo
    Jung, Jinhyoung
    Eun, Yeonghee
    Lee, Hyun
    Park, Junhee
    Shin, Dong Wook
    Lee, Sei Won
    CHEST, 2024, 165 (06) : 1362 - 1371
  • [30] Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritis
    Strand, Vibeke
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (03) : 193 - 205
12345